Clincosm LogoSign in Get a demo

thyroid associated ophthalmopathy

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Thyroid Associated Ophthalmopathy Trial in Guangzhou (immunosuppressive agent)

Recruiting
  • Thyroid Associated Ophthalmopathy
  • immunosuppressive agent
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 7, 2021

Thyroid Associated Ophthalmopathy Trial in Guangzhou (Doxycycline Hyclate)

Recruiting
  • Thyroid Associated Ophthalmopathy
  • Doxycycline Hyclate
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 7, 2021

Thyroid Associated Ophthalmopathy Trial in Guangzhou (combination of orbital compression surgery and strabismus surgery, orbital

Not yet recruiting
  • Thyroid Associated Ophthalmopathy
  • combination of orbital compression surgery and strabismus surgery
  • orbital compression
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Jun 6, 2021

Thyroid Associated Ophthalmopathy Trial in Guangzhou (Glucocorticoids)

Recruiting
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
May 15, 2021

Natural History and Risk Factors of TAO

Unknown status
  • Thyroid Associated Ophthalmopathy
  • DNA extraction and genetic characterization
  • +2 more
  • Guangzhou, China
  • +1 more
Sep 20, 2019

Thyroid Associated Ophthalmopathy Trial in Guangzhou (Glucocorticoids)

Unknown status
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    the Third Affiliated Hospital of Southern Medical University
Apr 16, 2017